What are Semaglutide and Tirzepatide?

Semaglutide and Tirzepatide are FDA approved medications for weight loss in individuals with obesity or overweight. Both medications mimic the effects of hormones that regulate blood sugar and appetite.

Semaglutide mimics the effect of GLP-1 (glucagon-like peptide-1), helping control blood sugar, reduce appetite, and promote weight loss.

Tirzepatide is a dual agonist, meaning it mimics both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), another hormone that also stimulates insulin release and fullness signals.

Key Differences

Tirzepatide has a dual action, affecting both GLP-1 and GIP receptors, potentially leading to greater weight loss than semaglutide.